Women with a family history of breast cancer could be offered preventative medication on the NHS under new plans outlined by the health regulator.
Officials are examining whether women who are at "high risk" of developing the disease should be offered hormone therapy to prevent breast cancer.
The National Institute of Health and Clinical Excellence (Nice) has launched a draft consultation to see whether drugs tamoxifen or raloxifene should be offered to high-risk post-menopausal women in England and Wales.
More top news
Uber may have broken UK law when it hushed up a major hack affecting 57 million customers and drivers worldwide, a minister has said.
The UN has described the treatment of Rohingya Muslims in Myanmar as a 'textbook case of ethnic cleansing'.
A UK study will explore whether dementia is more common in ex-professional footballers than in the normal population.